上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1290Please respect copyright.PENANAksJFjuEbSA
1290Please respect copyright.PENANAx5OnrS8Bv3
上集:https://www.penana.com/article/4711251290Please respect copyright.PENANATqPlmuyCMo
1290Please respect copyright.PENANAWzXwGjaOH11290Please respect copyright.PENANAzLCCQYzCgE
1290Please respect copyright.PENANAi267ImF475
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1290Please respect copyright.PENANAPJGsTSNP8d
1290Please respect copyright.PENANAgWVWP7csGu
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1290Please respect copyright.PENANAbiB2E990j4
1290Please respect copyright.PENANAUnPYWV2gQu
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1290Please respect copyright.PENANANTFMCJgXrJ
1290Please respect copyright.PENANAjDOi6cZjzI1290Please respect copyright.PENANA4laaECYeTq
1290Please respect copyright.PENANAlMGRSKJw6y
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1290Please respect copyright.PENANA9Ef8j2qXWU
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1290Please respect copyright.PENANAelJ1ub2Hd0
1290Please respect copyright.PENANAU1E6gZQW8A
忘記甚麼是Neoantigen的話,可重溫上一集。1290Please respect copyright.PENANA3JxKtm0vYg
1290Please respect copyright.PENANAeCWgNCvEcL
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1290Please respect copyright.PENANAH3h27tzsRp
1290Please respect copyright.PENANA7yzWiQQ3ox
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1290Please respect copyright.PENANA0kXaAU3wMS
1290Please respect copyright.PENANAzVBgaSyLEa1290Please respect copyright.PENANAKxV35kBXWM
1290Please respect copyright.PENANAhyYOosgCcQ
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1290Please respect copyright.PENANAL5MbPmFvmQ
1290Please respect copyright.PENANA2RDoA0WqAN
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1290Please respect copyright.PENANAZTovLSsC0P
1290Please respect copyright.PENANAXqYCgThuns
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1290Please respect copyright.PENANAXRLQqaOszd1290Please respect copyright.PENANA51XXmQfGMg
1290Please respect copyright.PENANA9ORVjJmIXq
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1290Please respect copyright.PENANAwVoueEEB3f
1290Please respect copyright.PENANAYLjrqwUeCy
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1290Please respect copyright.PENANAMsZ781XgJP1290Please respect copyright.PENANAaYCajJ145O
1290Please respect copyright.PENANA4FhjRIuzLi
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1290Please respect copyright.PENANAmgcjNFKxBF
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1290Please respect copyright.PENANAmurFYa7jde
1290Please respect copyright.PENANAOympjUyVJV
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1290Please respect copyright.PENANA6dReBYDNWV
1290Please respect copyright.PENANAoJm2OzJxjy
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1290Please respect copyright.PENANAruZLzgLlkk
1290Please respect copyright.PENANA7cK0mlAemU
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1290Please respect copyright.PENANAFX8VTOsh2F
1290Please respect copyright.PENANAkAd3b2Z2AU
1290Please respect copyright.PENANAa9UZLvZoKk
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1290Please respect copyright.PENANAz26v6UxgDu
1290Please respect copyright.PENANARfVINmFVFv
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1290Please respect copyright.PENANA4MGUoD1uLC
1290Please respect copyright.PENANA2Hz2UzKD48
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1290Please respect copyright.PENANA1nxgSJox9I
1290Please respect copyright.PENANAHLr7eCakZW
Link:1290Please respect copyright.PENANA7Nqy2W8MUh
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1290Please respect copyright.PENANAzxTjf11J2v
1290Please respect copyright.PENANAbXSyKNBdHN
1290Please respect copyright.PENANAge8at3ITuS
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1290Please respect copyright.PENANAib8f8zVCiX